Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Improving prognosis for patients with hepatocellular carcinoma in Ireland 1994-2008.

Gaynor C, Iqbal M, Comber H, Deady S, McCormick PA.

Eur J Gastroenterol Hepatol. 2017 Feb;29(2):221-224. doi: 10.1097/MEG.0000000000000756.

PMID:
27832038
2.

The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?

Yim SY, Seo YS, Jung CH, Kim TH, Lee JM, Kim ES, Keum B, Jong YK, An H, Kim JH, Yim HJ, Kim DS, Jeen YT, Yeon JE, Lee HS, Chun HJ, Byun KS, Um SH, Kim CD, Ryu HS.

Liver Int. 2016 Mar;36(3):445-53. doi: 10.1111/liv.12960. Epub 2015 Oct 12.

PMID:
26352789
3.

Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study.

Jepsen P, Andersen MW, Villadsen GE, Ott P, Vilstrup H.

Liver Int. 2017 Jun;37(6):871-878. doi: 10.1111/liv.13340. Epub 2017 Jan 2.

PMID:
27943604
4.

Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.

Weinmann A, Koch S, Niederle IM, Schulze-Bergkamen H, König J, Hoppe-Lotichius M, Hansen T, Pitton MB, Düber C, Otto G, Schuchmann M, Galle PR, Wörns MA.

J Clin Gastroenterol. 2014 Mar;48(3):279-89. doi: 10.1097/MCG.0b013e3182a8a793.

PMID:
24045276
5.

Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan.

Arii S, Okamoto E, Imamura M.

Semin Surg Oncol. 1996 May-Jun;12(3):204-11.

PMID:
8727612
6.
7.

Epidemiological trends of hepatocellular carcinoma in Austria.

Pinter M, Hucke F, Zielonke N, Trauner M, Sieghart W, Peck-Radosavljevic M.

Dig Dis. 2014;32(6):664-9. doi: 10.1159/000367983. Epub 2014 Oct 29.

PMID:
25376282
8.

Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.

Fenoglio L, Serraino C, Castagna E, Cardellicchio A, Pomero F, Grosso M, Senore C.

World J Gastroenterol. 2013 Jun 7;19(21):3207-16. doi: 10.3748/wjg.v19.i21.3207.

9.

Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.

Hong TP, Gow P, Fink M, Dev A, Roberts S, Nicoll A, Lubel J, Kronborg I, Arachchi N, Ryan M, Kemp W, Knight V, Farrugia H, Thursfield V, Desmond P, Thompson AJ, Bell S.

Hepatology. 2016 Apr;63(4):1205-12. doi: 10.1002/hep.28267. Epub 2016 Feb 19.

PMID:
26435297
10.

The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma.

Taura N, Hamasaki K, Nakao K, Ichikawa T, Nishimura D, Goto T, Fukuta M, Kawashimo H, Fujimoto M, Kusumoto K, Motoyoshi Y, Shibata H, Eguchi K.

Clin Gastroenterol Hepatol. 2006 Sep;4(9):1177-83. Epub 2006 Aug 8.

PMID:
16901768
11.

Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.

Hsin IF, Hsu CY, Huang HC, Huang YH, Lin HC, Lee RC, Chiang JH, Lee FY, Huo TI, Lee SD.

J Clin Gastroenterol. 2011 Jul;45(6):556-62. doi: 10.1097/MCG.0b013e318210ff17.

PMID:
21666547
12.

Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular Carcinoma.

Ha Y, Han S, Shim JH, Ko GY, Yoon HK, Sung KB, Lee D, Kim KM, Lim YS, Chung YH, Lee YS, Lee HC.

J Vasc Interv Radiol. 2015 Aug;26(8):1093-1101.e1. doi: 10.1016/j.jvir.2015.04.010. Epub 2015 Jun 13.

PMID:
26077020
13.

Treatment and prognosis of hepatocellular carcinoma: a population based study in France.

Borie F, Bouvier AM, Herrero A, Faivre J, Launoy G, Delafosse P, Velten M, Buemi A, Peng J, Grosclaude P, Trétarre B.

J Surg Oncol. 2008 Dec 1;98(7):505-9. doi: 10.1002/jso.21159.

PMID:
18932235
14.

Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.

Witjes CD, Karim-Kos HE, Visser O, van den Akker SA, de Vries E, Ijzermans JN, de Man RA, Coebergh JW, Verhoef C.

Eur J Gastroenterol Hepatol. 2012 Apr;24(4):450-7. doi: 10.1097/MEG.0b013e32835030ce.

PMID:
22273986
15.

Active treatments are a rational approach for hepatocellular carcinoma in elderly patients.

Suda T, Nagashima A, Takahashi S, Kanefuji T, Kamimura K, Tamura Y, Takamura M, Igarashi M, Kawai H, Yamagiwa S, Nomoto M, Aoyagi Y.

World J Gastroenterol. 2013 Jun 28;19(24):3831-40. doi: 10.3748/wjg.v19.i24.3831.

16.

Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.

Yamamoto Y, Ikoma H, Morimura R, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E.

Anticancer Res. 2013 Nov;33(11):5097-105.

PMID:
24222155
17.

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Altekruse SF, McGlynn KA, Reichman ME.

J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753. Epub 2009 Feb 17.

18.

Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database.

Cohen MJ, Levy I, Barak O, Bloom AI, Fernández-Ruiz M, Di Maio M, Perrone F, Poon RT, Shouval D, Yau T, Shibolet O.

Liver Int. 2014 Aug;34(7):1109-17. doi: 10.1111/liv.12486. Epub 2014 Apr 4.

PMID:
24512125
19.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

20.

Presentation and outcomes of hepatocellular carcinoma patients at a western centre.

Kitisin K, Packiam V, Steel J, Humar A, Gamblin TC, Geller DA, Marsh JW, Tsung A.

HPB (Oxford). 2011 Oct;13(10):712-22. doi: 10.1111/j.1477-2574.2011.00362.x. Epub 2011 Aug 11.

Supplemental Content

Support Center